SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 114 TWD 2.24% Market Closed
Market Cap: 8.2B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

Relative Value

The Relative Value of one SciVision Biotech Inc stock under the Base Case scenario is 71.92 TWD. Compared to the current market price of 114 TWD, SciVision Biotech Inc is Overvalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
71.92 TWD
Overvaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
13
Median 3Y
7.8
Median 5Y
7.9
Industry
2.3
Forward
7.7
vs History
49
vs Industry
13
Median 3Y
30.6
Median 5Y
30.2
Industry
23
Forward
23.8
vs History
47
vs Industry
15
Median 3Y
25.2
Median 5Y
25.7
Industry
14.3
vs History
25
vs Industry
20
Median 3Y
18.5
Median 5Y
18.5
Industry
20
vs History
19
vs Industry
17
Median 3Y
3.1
Median 5Y
2.8
Industry
2.2
vs History
53
vs Industry
14
Median 3Y
7
Median 5Y
7.3
Industry
2.4
Forward
7.1
vs History
58
vs Industry
16
Median 3Y
10.2
Median 5Y
10.4
Industry
5
vs History
55
vs Industry
11
Median 3Y
19
Median 5Y
20.7
Industry
12.9
Forward
18.1
vs History
68
vs Industry
11
Median 3Y
26.3
Median 5Y
25.4
Industry
17.4
Forward
23.2
vs History
46
vs Industry
18
Median 3Y
23.1
Median 5Y
23.1
Industry
14
vs History
63
vs Industry
19
Median 3Y
26.1
Median 5Y
30
Industry
18.2
vs History
12
vs Industry
16
Median 3Y
3.3
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
SciVision Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
SciVision Biotech Inc
TWSE:1786
8B TWD 9.6 37.1 23.7 29.7
JP
Hoya Corp
TSE:7741
7T JPY 8.5 35.6 23.5 28.3
CH
Alcon AG
SIX:ALC
37.9B CHF 4.3 35.8 17.6 34.1
DK
Coloplast A/S
CSE:COLO B
178.7B DKK 6.6 35.4 22.8 26.8
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 199.1 -55.7 -85.7 -80.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
49B CNY 11.1 26.5 23 23
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 56
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.5 264.6 462.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.6 23.7 38.9
P/E Multiple
Earnings Growth PEG
TW
SciVision Biotech Inc
TWSE:1786
Average P/E: 34.1
37.1
N/A N/A
JP
Hoya Corp
TSE:7741
35.6
15%
2.4
CH
Alcon AG
SIX:ALC
35.8
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.4
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.5
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.5
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TW
SciVision Biotech Inc
TWSE:1786
Average EV/EBITDA: 44.4
23.7
N/A N/A
JP
Hoya Corp
TSE:7741
23.5
15%
1.6
CH
Alcon AG
SIX:ALC
17.6
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.8
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.4
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.6
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.6
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.7
22%
1.1